Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $41.06 in the prior trading day, Revolution Medicines Inc (NASDAQ: RVMD) closed at $40.94, down -0.29%. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 1.32 million shares were traded. RVMD stock price reached its highest trading level at $41.6 during the session, while it also had its lowest trading level at $40.45.

Ratios:

Our goal is to gain a better understanding of RVMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 05, 2025, initiated with a Buy rating and assigned the stock a target price of $99.

On August 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75. On August 15, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $67.Wells Fargo initiated its Overweight rating on August 15, 2025, with a $67 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 03 ’25 when Anders Jack sold 5,238 shares for $40.17 per share. The transaction valued at 210,432 led to the insider holds 113,314 shares of the business.

Anders Jack sold 4,762 shares of RVMD for $190,560 on Sep 02 ’25. The Chief Financial Officer now owns 113,314 shares after completing the transaction at $40.02 per share. On Sep 02 ’25, another insider, JACK LEE ANDERS, who serves as the Officer of the company, bought 10,000 shares for $37.97 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 7653036544 and an Enterprise Value of 5648660992.

Stock Price History:

The Beta on a monthly basis for RVMD is 1.22, which has changed by -0.017282784 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 9.20%, while the 200-Day Moving Average is calculated to be 1.41%.

Shares Statistics:

The stock has traded on average 2.25M shares per day over the past 3-months and 1975160 shares per day over the last 10 days, according to various share statistics. A total of 186.90M shares are outstanding, with a floating share count of 162.02M. Insiders hold about 13.33% of the company’s shares, while institutions hold 91.90% stake in the company. Shares short for RVMD as of 1755216000 were 15175192 with a Short Ratio of 6.75, compared to 1752537600 on 13662930. Therefore, it implies a Short% of Shares Outstanding of 15175192 and a Short% of Float of 8.64.

Earnings Estimates

A comprehensive evaluation of Revolution Medicines Inc (RVMD) is underway, with the input of 12.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$1.52, with high estimates of -$1.2 and low estimates of -$1.73.

Analysts are recommending an EPS of between -$4.69 and -$5.62 for the fiscal current year, implying an average EPS of -$5.3. EPS for the following year is -$5.9, with 13.0 analysts recommending between -$4.47 and -$7.69.